AACR logo

More articles from Cancer Biology and Signal Transduction

In Vitro and In Vivo Synergistic Antitumor Activity of the Combination of BKM120 and Erlotinib in Head and Neck Cancer: Mechanism of Apoptosis and Resistance
Abu Syed Md Anisuzzaman, Abedul Haque, Dongsheng Wang, Mohammad Aminur Rahman, Chao Zhang, Zhengjia Chen, Zhuo Georgia Chen, Dong M. Shin, A.R.M. Ruhul Amin

Molecular Cancer Therapeutics Apr 2017, 16 (4) 729-738; DOI: 10.1158/1535-7163.MCT-16-0683
Ras–MEK Signaling Mediates a Critical Chk1-Dependent DNA Damage Response in Cancer Cells
Ho-June Lee, Yi Cao, Victoria Pham, Elizabeth Blackwood, Catherine Wilson, Marie Evangelista, Christiaan Klijn, David Stokoe, Jeff Settleman

Molecular Cancer Therapeutics Apr 2017, 16 (4) 694-704; DOI: 10.1158/1535-7163.MCT-16-0504
Co-targeting HGF/cMET Signaling with MEK Inhibitors in Metastatic Uveal Melanoma
Hanyin Cheng, Vivian Chua, Connie Liao, Timothy J. Purwin, Mizue Terai, Ken Kageyama, Michael A. Davies, Takami Sato, Andrew E. Aplin

Molecular Cancer Therapeutics Mar 2017, 16 (3) 516-528; DOI: 10.1158/1535-7163.MCT-16-0552
MET Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR-mutant Lung Cancer
Shigeki Nanjo, Sachiko Arai, Wei Wang, Shinji Takeuchi, Tadaaki Yamada, Akito Hata, Nobuyuki Katakami, Yasunori Okada, Seiji Yano

Molecular Cancer Therapeutics Mar 2017, 16 (3) 506-515; DOI: 10.1158/1535-7163.MCT-16-0522
Bone-Seeking Matrix Metalloproteinase-2 Inhibitors Prevent Bone Metastatic Breast Cancer Growth
Marilena Tauro, Gemma Shay, Samer S. Sansil, Antonio Laghezza, Paolo Tortorella, Anthony M. Neuger, Hatem Soliman, Conor C. Lynch

Molecular Cancer Therapeutics Mar 2017, 16 (3) 494-505; DOI: 10.1158/1535-7163.MCT-16-0315-T
Dimethyl Fumarate Controls the NRF2/DJ-1 Axis in Cancer Cells: Therapeutic Applications
Nathaniel Edward Bennett Saidu, Gaëlle Noé, Olivier Cerles, Luc Cabel, Niloufar Kavian-Tessler, Sandrine Chouzenoux, Mathilde Bahuaud, Christiane Chéreau, Carole Nicco, Karen Leroy, Bruno Borghese, François Goldwasser, Frédéric Batteux, Jérôme Alexandre

Molecular Cancer Therapeutics Mar 2017, 16 (3) 529-539; DOI: 10.1158/1535-7163.MCT-16-0405
Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial–Stromal Tumors by Targeting PDGFR-β
Elena Jachetti, Alice Rigoni, Lucia Bongiovanni, Ivano Arioli, Laura Botti, Mariella Parenza, Valeria Cancila, Claudia Chiodoni, Fabrizio Festinese, Matteo Bellone, Regina Tardanico, Claudio Tripodo, Mario P. Colombo

Molecular Cancer Therapeutics Feb 2017, 16 (2) 365-375; DOI: 10.1158/1535-7163.MCT-16-0466
Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation
Yang Quan-Jun, Huo Yan, Han Yong-Long, Wan Li-Li, Li Jie, Huang Jin-Lu, Lu Jin, Chen Peng-Guo, Gan Run, Guo Cheng

Molecular Cancer Therapeutics Feb 2017, 16 (2) 334-343; DOI: 10.1158/1535-7163.MCT-16-0324
Dual Inhibition of MEK and PI3K/Akt Rescues Cancer Cachexia through both Tumor-Extrinsic and -Intrinsic Activities
Erin E. Talbert, Jennifer Yang, Thomas A. Mace, Matthew R. Farren, Alton B. Farris, Gregory S. Young, Omar Elnaggar, Zheng Che, Cynthia D. Timmers, Priyani Rajasekera, Jennifer M. Maskarinec, Mark Bloomston, Tanios Bekaii-Saab, Denis C. Guttridge, Gregory B. Lesinski

Molecular Cancer Therapeutics Feb 2017, 16 (2) 344-356; DOI: 10.1158/1535-7163.MCT-16-0337
Characterization of EGFR T790M, L792F, and C797S Mutations as Mechanisms of Acquired Resistance to Afatinib in Lung Cancer
Yoshihisa Kobayashi, Koichi Azuma, Hiroki Nagai, Young Hak Kim, Yosuke Togashi, Yuichi Sesumi, Masato Chiba, Masaki Shimoji, Katsuaki Sato, Kenji Tomizawa, Toshiki Takemoto, Kazuto Nishio, Tetsuya Mitsudomi

Molecular Cancer Therapeutics Feb 2017, 16 (2) 357-364; DOI: 10.1158/1535-7163.MCT-16-0407

Main menu

User menu

Search

More articles from Cancer Biology and Signal Transduction

Pages

Articles

Info for

About MCT